Taiho Ventures

Taiho Ventures, LLC serves as the corporate venture capital arm of Taiho Pharmaceutical Co., Ltd., focusing on strategic investments in early-stage private biotech ventures globally. Its primary areas of interest align with its parent company's strengths—oncology, allergy/immunology, and urology. With $400 million under management as of recent reports, it supports innovative science through equity investments, option deals, spinouts, and company creation. Notable contributions include expanding Taiho Pharmaceutical’s development pipeline by investing in Arcus Biosciences and Cullinan Pearl Inc., leading to licensing agreements for novel oncology agents.